Added to YB: 2020-11-08
Pitch date: 2020-11-08
SUPN:US [bullish]
Supernus Pharmaceuticals, Inc.
+102.57%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
Market Cap
$2.9B
Pitch Price
$24.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
19.98
P/E
-148.40
EV/Sales
3.91
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Supernus Pharmaceuticals, Inc. SUPN:US
A summary for this pitch has not been created yet.
Read full article (0 min)